Table 2.
Adverse reaction spectrum of UGT1A1*6 and UGT1A1*28
| Adverse reaction | UGT1A1*6 | P | UGT1A1*28 | P | ||
| WT (n=64) | HM (n=43) | WT (n=81) | HM (n=26) | |||
| Vomit grade | 0.020 | 0.013 | ||||
| 0 | 30 (46.88%) | 16 (37.21%) | 41 (50.62%) | 5 (19.23%) | ||
| 1-2 | 25 (39.06%) | 11 (25.58%) | 25 (30.86%) | 11 (42.31%) | ||
| 3-4 | 9 (14.06%) | 16 (37.21%) | 15 (18.52%) | 10 (38.46%) | ||
| Mucositis | 0.322 | 0.005 | ||||
| Yes | 46 (71.88%) | 27 (62.79%) | 61 (75.31%) | 12 (46.15%) | ||
| No | 18 (28.12%) | 16 (37.21%) | 20 (24.69%) | 14 (53.85%) | ||
| Diarrhea grade | 0.027 | 0.382 | ||||
| 0-2 | 50 (78.12%) | 25 (58.14%) | 55 (67.90%) | 20 (76.92%) | ||
| 3-4 | 14 (21.88%) | 18 (41.86%) | 26 (32.10%) | 6 (23.08%) | ||
| Neutropenia grade | 0.005 | 0.241 | ||||
| 0-2 | 43 (67.19%) | 17 (39.53%) | 48 (59.26%) | 12 (46.15%) | ||
| 3-4 | 21 (32.81%) | 26 (60.47%) | 33 (40.74%) | 14 (53.85%) | ||
| Anemia | 0.654 | 0.820 | ||||
| Yes | 53 (82.81%) | 37 (86.05%) | 69 (85.19%) | 21 (80.77%) | ||
| No | 11 (17.19%) | 6 (13.95%) | 12 (14.81%) | 5 (19.23%) | ||
| Thrombocytopenia | 0.481 | 0.510 | ||||
| Yes | 54 (84.38%) | 34 (79.07%) | 65 (80.25%) | 23 (88.46%) | ||
| No | 10 (15.62%) | 9 (20.93%) | 16 (19.75%) | 3 (11.54%) | ||
| Fatigue | 0.654 | 0.697 | ||||
| Yes | 53 (82.81%) | 37 (86.05%) | 67 (82.72%) | 23 (88.46%) | ||
| No | 11 (17.19%) | 6 (13.95%) | 14 (17.28%) | 3 (11.54%) | ||